EGFR and triple-negative breast carcinoma: Similarly, TET1, an epigenetic modulator overexpressed in CAFs, reshapes the CAF epigenome by hypomethylating oncogenic pathways (e.g., PI3K, EGFR, PDGF) in triple-negative breast cancer [39].